| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC9141 | Brompheniramine hydrogen maleate | Brompheniramine maleate is a histamine H1 receptors antagonist. |
|
| DCAPI1392 | BTZ043 racemate Featured | BTZ043 racemate is a decaprenylphosphoryl-β-D-ribose 2-epimerase (DprE1) inhibitor acting as a new antimycobacterial agent that kill Mycobacterium tuberculosis. |
|
| DCAPI1209 | Budesonide | Budesonide |
|
| DCAPI1160 | Buflomedil HCl | Buflomedil HCl |
|
| DCAPI1459 | Bupivacaine HCL | Bupivacaine HCL |
|
| DC8995 | Busulfan/Myleran | Busulfan is a bifunctional alkylating agent. |
|
| DCAPI1407 | Butenafine | Butenafine |
|
| DCAPI1559 | Calcifediol Featured | Calcifediol is a major circulating metabolite of vitamin D3, acting as a competitive inhibitor with an apparent Ki of 3.9 μM, suppresses PTH secretion and mRNA (ED50=2 nM). |
|
| DCAPI1415 | Calcipotriol(Calcipotriene) Featured | Calcipotriol is a synthetic VitD3 analogue with a high affinity for the vitamin D receptor. |
|
| DCAPI1351 | Calcium levofolinate (Calcium Folinate) | Calcium levofolinate (Calcium Folinate) |
|
| DC9185 | Candesartan cilexetil Featured | Candesartan Cilexetil (TCV-116) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. |
|
| DC9142 | Candesartan | Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM. |
|
| DC8975 | Captopril | Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE). |
|
| DC9193 | Carbamazepine Featured | Carbamazepine, a sodium channel blocker, is an anticonvulsant drug. |
|
| DCAPI1210 | Carbazochrome sodium sulfonate | Carbazochrome sodium sulfonate |
|
| DC9173 | Carbetapentane citrate | Carbetapentane citrate is a selective inhibitor of the cough, with mild atropine-like effect and local anesthesia effect. |
|
| DC9095 | Carboplatin Featured | Carboplatin is a chemotherapy drug by binding to DNA and interfering with the cell's repair mechanism. |
|
| DC9012 | Carisoprodol | Carisoprodol is a centrally acting skeletal muscle relaxant of the carbamate class and produces all the effects associated with barbiturate receptor ligands. |
|
| DC8972 | Carmustine Featured | Carmustine is a cell-cycle phase nonspecific alkylating antineoplastic agent. |
|
| DC9119 | Carvedilol | Carvedilol(BM14190) is a non-selective beta blocker/alpha-1 blocker with an IC50 of 3.8 μM for inhibition of LDL oxidation. |
|
| DCAPI1130 | Catharanthine | Catharanthine inhibits nicotinic receptor mediated diaphragm contractions with IC50 of 59.6 µM. |
|
| DCAPI1119 | Cathepsin Inhibitor 1 Featured | Cathepsin Inhibitor 1 is an inhibitor of Cathepsin (L, L2, S, K, B) with pIC50 of 7.9, 6.7, 6.0, 5.5 and 5.2, respectively. |
|
| DCAPI1386 | Cefdinir (Omnicef) | Cefdinir (Omnicef) |
|
| DCAPI1024 | Cefditoren pivoxil | Cefditoren pivoxil |
|
| DCAPI1038 | Cefoselis sulfate | Cefoselis sulfate |
|
| DCAPI1033 | Cefprozil hydrate (Cefzil) | Cefprozil hydrate (Cefzil) |
|
| DCAPI1491 | Celecoxib Featured | Celecoxib is a selective Cox-2 inhibitor (IC50 of 40 nM). Celecoxib shows low sensitivity against Cox-1 (IC50 of 15 μM). Celecoxib shows an anti-proliferative effect on nasopharyngeal carcinoma (NPC) cell lines including HNE1 (IC50of 32.86 μM) and CNE1-LM |
|
| DC9154 | Cetirizine 2HCl | Cetirizine 2Hcl, a second-generation antihistamine, is a major metabolite of hydroxyzine, and a racemic selective H1 receptor inverse agonist used in the treatment of allergies, hay fever, angioedema, and urticaria. |
|
| DC9048 | Chloroambucil | Chlorambucil(WR-139013; CB-1348) is a chemotherapy drug that has been mainly used in the treatment of chronic lymphocytic leukemia. |
|
| DCAPI1255 | Chloramphenicol (Chloromycetin) | Chloramphenicol (Chloromycetin) |
|
